Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis

Superficial esophageal squamous cell carcinoma (ESCC) is generally considered a subtype of less invasive ESCC. Yet a subset of these superficial ESCC would have metastasis after esophagostomy or endoscopic resection and lead to poor prognosis. The objective of this study is to determine biomarkers that can identify such subset of superficial ESCC that would have metastasis after surgery using genome wide copy number alteration (CNA) analyses. The CNAs of 38 cases of superficial ESCCs originated from radical surgery, including 19 without metastasis and 19 with metastasis within 5 years’ post-surgery, were analyzed using Affymetrix OncoScan™ FFPE Assay. A 39-gene signature was identified which characterized the subset of superficial ESCC with high risk of metastasis after surgery. In addition, recurrent CNAs of superficial ESCC were also investigated in the study. Amplification of 11q13.3 (FGF4) and deletion of 9p21.3 (CDKN2A) were found to be recurrent in all 38 superficial ESCCs analyzed. Notably amplifications of 3p26.33 (SOX2OT), 8q24.21 (MYC), 14q21.1 (FOXA1) and deletion of 3p12.1 (GBE1) were only found to be recurrent in metastaic superficial ESCCs. In conclusion, using CNAs analyses, we identify a 39-gene signature which characterizes the high risk metastatic superficial ESCCs and discover several recurrent CNAs that might be the driver alterations in metastasis among superficial ESCCs.

[1]  I. Sohn,et al.  A seven‐gene signature can predict distant recurrence in patients with triple‐negative breast cancers who receive adjuvant chemotherapy following surgery , 2015, International journal of cancer.

[2]  A 41-gene signature derived from breast cancer stem cells as a predictor of survival , 2014, Journal of experimental & clinical cancer research : CR.

[3]  R. Winqvist,et al.  Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families , 2010, Familial Cancer.

[4]  T. Boyer.  Special article the glutathione S‐transferases: An update , 1989 .

[5]  M. Askarian-Amiri,et al.  Emerging Role of Long Non-Coding RNA SOX2OT in SOX2 Regulation in Breast Cancer , 2014, PloS one.

[6]  J. Luketich,et al.  Oesophageal carcinoma , 2013, The Lancet.

[7]  S. Elledge,et al.  Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. , 1997, Science.

[8]  T. Halazonetis,et al.  Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.

[9]  Kui Liu,et al.  Lack of any association of GST genetic polymorphisms with susceptibility to ovarian cancer--a meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[10]  C. Langford,et al.  Genome-Wide Screening for Genetic Alterations in Esophageal Cancer by aCGH Identifies 11q13 Amplification Oncogenes Associated with Nodal Metastasis , 2012, PloS one.

[11]  A. Egashira,et al.  Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis , 2002, Cancer.

[12]  Azra Yasmin,et al.  Epidemiological factors related to GSTM1 and GSTT1 genes deletion in colon and rectum cancers: A case-control study. , 2015, Cancer biomarkers : section A of Disease markers.

[13]  Jiri Bartek,et al.  Replication stress links structural and numerical cancer chromosomal instability , 2013, Nature.

[14]  Franck Picard,et al.  Preprocessing and downstream analysis of microarray DNA copy number profiles , 2011, Briefings Bioinform..

[15]  David E. Misek,et al.  The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. , 2002, Cancer research.

[16]  Derek Y. Chiang,et al.  Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.

[17]  Yan Wang,et al.  Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  M. Holden,et al.  Identification of eight candidate target genes of the recurrent 3p12–p14 loss in cervical cancer by integrative genomic profiling , 2013, The Journal of pathology.

[19]  Pei Zhang,et al.  Forkhead box protein A1 is a prognostic predictor and promotes tumor growth of gastric cancer , 2015, OncoTargets and therapy.

[20]  Jian Sun,et al.  Genetic landscape of esophageal squamous cell carcinoma , 2014, Nature Genetics.

[21]  Mef Nilbert,et al.  Prognostic Impact of Array-based Genomic Profiles in Esophageal Squamous Cell Cancer , 2008, BMC Cancer.

[22]  H. Barr,et al.  Endoscopic therapies for the prevention and treatment of early esophageal neoplasia , 2011, Expert review of gastroenterology & hepatology.

[23]  Qiang Feng,et al.  Identification of genomic alterations in oesophageal squamous cell cancer , 2014, Nature.

[24]  E. Thomas,et al.  GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. , 2001, Carcinogenesis.

[25]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[26]  David E. Misek,et al.  The Hepatocyte Nuclear Factor 3 α Gene, HNF3α (FOXA1), on Chromosome Band 14q13 Is Amplified and Overexpressed in Esophageal and Lung Adenocarcinomas , 2002 .

[27]  A. Rosenwald,et al.  Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms , 2005, Leukemia.

[28]  S. Tavaré,et al.  High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer , 2007, Genome Biology.

[29]  Youwei Zhang,et al.  Roles of Chk1 in cell biology and cancer therapy , 2014, International journal of cancer.

[30]  T. Boyer.  The glutathione S-transferases: an update. , 1989, Hepatology.

[31]  M. Wang,et al.  Identification of putative target genes for amplification within 11q13.2 and 3q27.1 in esophageal squamous cell carcinoma , 2014, Clinical and Translational Oncology.

[32]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[33]  Yun-chi Tang,et al.  Gene Copy-Number Alterations: A Cost-Benefit Analysis , 2013, Cell.

[34]  Junmin Li,et al.  GSTT1 Deletion Is Related to Polycyclic Aromatic Hydrocarbons-Induced DNA Damage and Lymphoma Progression , 2014, PloS one.

[35]  M. Wigler,et al.  Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach , 2006, Cell.

[36]  Thomas D. Wu,et al.  Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes , 2009, Molecular Cancer Research.

[37]  Nan Hu,et al.  Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China. , 2009, Cancer research.

[38]  M. Loda,et al.  FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma , 2009, Clinical Cancer Research.

[39]  J. Inazawa,et al.  Genomic copy‐number alterations of MYC and FHIT genes are associated with survival in esophageal squamous‐cell carcinoma , 2012, Cancer science.

[40]  S. Badve,et al.  Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications , 2008, Journal of Clinical Pathology.

[41]  Q. Zhan,et al.  Consistent and Differential Genetic Aberrations between Esophageal Dysplasia and Squamous Cell Carcinoma Detected By Array Comparative Genomic Hybridization , 2013, Clinical Cancer Research.

[42]  Y. Tachimori,et al.  Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases , 2006, Modern Pathology.

[43]  A. Regev,et al.  SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.

[44]  Jan Hellemans,et al.  Accurate and objective copy number profiling using real-time quantitative PCR. , 2010, Methods.

[45]  M. Taniwaki,et al.  SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma. , 2010, Cancer genetics and cytogenetics.

[46]  M. Vasei,et al.  Two Novel Splice Variants of SOX2OT, SOX2OT‐S1, and SOX2OT‐S2 are Coupregulated with SOX2 and OCT4 in Esophageal Squamous Cell Carcinoma , 2014, Stem cells.

[47]  C. Hayward,et al.  Mutations in SOX2 cause anophthalmia , 2003, Nature Genetics.

[48]  N. Uedo,et al.  Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. , 2008, Gastrointestinal endoscopy.